Home » Stocks » Citius Pharmaceuticals

Citius Pharmaceuticals, Inc. (CTXR)

Stock Price: $1.22 USD 0.12 (10.91%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 55.13M
Revenue (ttm) n/a
Net Income (ttm) -16.80M
Shares Out 45.19M
EPS (ttm) -0.62
PE Ratio n/a
Forward PE 1.23
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $1.22
Previous Close $1.10
Change ($) 0.12
Change (%) 10.91%
Day's Open 1.10
Day's Range 1.08 - 1.23
Day's Volume 2,266,507
52-Week Range 0.40 - 1.97

More Stats

Market Cap 55.13M
Enterprise Value 51.99M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 45.19M
Float 24.53M
EPS (basic) -0.64
EPS (diluted) -0.62
FCF / Share -0.47
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 952,298
Short Ratio 0.45
Short % of Float 2.89%
Beta 1.21
PE Ratio n/a
Forward PE 1.23
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.77
Revenue n/a
Operating Income -16.96M
Net Income -16.80M
Free Cash Flow -16.01M
Net Cash 3.14M
Net Cash / Share 0.07
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -41.80%
ROE -77.58%
ROIC -99.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(350.82% upside)
Current: 1.22
Target: 5.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-15.60-13.79-9.99-7.45-3.23-1.18-1.02
Net Income-15.56-12.54-10.38-8.30-2.90-1.29-1.05
Shares Outstanding20.1610.735.483.622.121.181.13
Earnings Per Share-0.77-1.17-1.89-2.29-1.37-1.05-0.90
Operating Cash Flow-12.44-11.32-7.97-5.90-2.39-1.10-0.92
Capital Expenditures-------
Free Cash Flow-12.44-11.32-7.97-5.90-2.39-1.10-0.92
Cash & Equivalents7.959.193.210.300.680.050.00
Total Debt0.
Net Cash / Debt7.789.013.03-0.380.68-2.580.00
Book Value24.3827.8721.9516.77-0.64-2.90-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Citius Pharmaceuticals, Inc.
Country United States
Employees 9
CEO Myron Z. Holubiak

Stock Information

Ticker Symbol CTXR
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CTXR


Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.